InvestorsHub Logo
Followers 8
Posts 1934
Boards Moderated 0
Alias Born 09/10/2012

Re: None

Friday, 06/10/2022 10:14:11 AM

Friday, June 10, 2022 10:14:11 AM

Post# of 7234
Milestones still hang

In June 2005, we entered into an acquisition agreement with Cephalon, Inc., or Cephalon, pursuant to which we divested the compound,
TRISENOX. Cephalon was subsequently acquired by Teva Pharmaceutical Industries Ltd., or Teva. Under this agreement, we have the right to receive up
to $100 million in payments upon achievement by Teva of specified sales and development milestones related to TRISENOX. To date, we have received
$60.0 million of such potential milestone payments as a result of having achieved certain sales milestones.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.